Cargando…
The Patent Ductus Arteriosus in Extremely Preterm Neonates Is More than a Hemodynamic Challenge: New Molecular Insights
Complications to preterm birth are numerous, including the presence of a patent ductus arteriosus (PDA). The biological understanding of the PDA is sparse and treatment remains controversial. Herein, we speculate whether the PDA is more than a cardiovascular imbalance, and may be a marker in respons...
Autores principales: | Sellmer, Anna, Henriksen, Tine Brink, Palmfeldt, Johan, Bech, Bodil Hammer, Astono, Julie, Bennike, Tue Bjerg, Hjortdal, Vibeke Elisabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496182/ https://www.ncbi.nlm.nih.gov/pubmed/36139018 http://dx.doi.org/10.3390/biom12091179 |
Ejemplares similares
-
Urinary Neutrophil Gelatinase-associated Lipocalin in the evaluation of Patent Ductus Arteriosus and AKI in Very Preterm Neonates: a cohort study
por: Sellmer, Anna, et al.
Publicado: (2017) -
When to Treat Hemodynamically Insignificant Patent Ductus Arteriosus in Preterm Infants
por: Al-Abdi, Sameer Y.
Publicado: (2012) -
N-Terminal Pro-B Type Natriuretic Peptide as a Marker of Bronchopulmonary Dysplasia or Death in Very Preterm Neonates: A Cohort Study
por: Sellmer, Anna, et al.
Publicado: (2015) -
Controversy in the diagnosis and treatment of hemodynamically significant patent ductus arteriosus in preterm infants
por: Sung, Se In
Publicado: (2019) -
Conservative Non-intervention Approach for Hemodynamically Significant Patent Ductus Arteriosus in Extremely Preterm Infants
por: Sung, Se In, et al.
Publicado: (2020)